L’Oréal Issues Voluntary Recall of Benzoyl Peroxide Products Over Benzene Concerns

March 11, 2025

L’Oréal announced it is recalling all lots of its acne treatment Effaclar Duo in the U.S. due to concerns over benzene contamination. The product, sold under the La Roche-Posay brand, contains benzoyl peroxide (BPO).

Valisure, an independent testing laboratory, first reported benzene contamination in several BPO-containing acne products more than a year ago, urging the US Food and Drug Administration (FDA) to take action.

Read further analysis at Dermatology Times >>

Previous coverage of reports studying benzene presence in topical acne products formulated with benzoyl peroxide:

Topics in Article

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Compounded Tirzepatide, NAD+ Injections Recalled Nationwide Over Sterility Concerns
    • Meliora Consulting Becomes Silver Vendor Affiliate with the American Med Spa Association
    • FDA Sends Peptide ‘Interim Access Policy’ to White House for Review
    • New ACOG Menopause Guidelines Expand Hormone Therapy and Symptom Treatment Recommendations
    • Galderma to Acquire ZO Skin Health for $1.5 Billion